NCT00036946 2016-06-03
VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Regeneron Pharmaceuticals
Phase 1 Completed
Clinical Trials
11 trialsNCT00045266 2016-06-03
VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma
Regeneron Pharmaceuticals
Phase 1 Completed
NCT00082823 2016-06-03
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Regeneron Pharmaceuticals
Phase 1 Completed
NCT00083213 2016-06-03
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Regeneron Pharmaceuticals
Phase 1 Completed
NCT00644124 2016-05-06
Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma
Sanofi
Phase 1 Completed
NCT00876044 2016-05-05
QUTIE
Sanofi
Phase 1 Completed
NCT01688960 2015-03-17
Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies
Regeneron Pharmaceuticals
Phase 1 Completed
NCT00545246 2013-10-16
A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients
Sanofi
Phase 1 Completed
NCT00921661 2012-11-09
Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer
Sanofi
Phase 1 Completed
NCT01148615 2012-01-13
A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors
Sanofi
Phase 1 Completed
NCT00479076 2011-01-26
A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients
Sanofi
Phase 1 Completed